AR204086A1 - Procedimiento para la preparacion de 1-(3-(4-m.clorofenil-1-piperazinil)-propil)-3,4-dietil-delta21,2,4-triazolino-5-ona - Google Patents

Procedimiento para la preparacion de 1-(3-(4-m.clorofenil-1-piperazinil)-propil)-3,4-dietil-delta21,2,4-triazolino-5-ona

Info

Publication number
AR204086A1
AR204086A1 AR250515A AR25051573A AR204086A1 AR 204086 A1 AR204086 A1 AR 204086A1 AR 250515 A AR250515 A AR 250515A AR 25051573 A AR25051573 A AR 25051573A AR 204086 A1 AR204086 A1 AR 204086A1
Authority
AR
Argentina
Prior art keywords
delta21
chlorophenil
dietil
triazolino
piperazinil
Prior art date
Application number
AR250515A
Other languages
English (en)
Spanish (es)
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of AR204086A1 publication Critical patent/AR204086A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AR250515A 1972-10-16 1973-01-01 Procedimiento para la preparacion de 1-(3-(4-m.clorofenil-1-piperazinil)-propil)-3,4-dietil-delta21,2,4-triazolino-5-ona AR204086A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT53380/72A IT1052119B (it) 1972-10-16 1972-10-16 Derivati del triazolinone e procedimento per la loro preparazione

Publications (1)

Publication Number Publication Date
AR204086A1 true AR204086A1 (es) 1975-11-20

Family

ID=11282276

Family Applications (1)

Application Number Title Priority Date Filing Date
AR250515A AR204086A1 (es) 1972-10-16 1973-01-01 Procedimiento para la preparacion de 1-(3-(4-m.clorofenil-1-piperazinil)-propil)-3,4-dietil-delta21,2,4-triazolino-5-ona

Country Status (19)

Country Link
US (1) US3857845A (bs)
JP (1) JPS5550948B2 (bs)
AR (1) AR204086A1 (bs)
AT (1) AT336021B (bs)
BE (1) BE806146A (bs)
CA (1) CA1013746A (bs)
CH (1) CH589643A5 (bs)
DE (1) DE2351739C3 (bs)
DK (1) DK141750B (bs)
ES (1) ES419687A1 (bs)
FI (1) FI58495C (bs)
FR (1) FR2202702B1 (bs)
GB (1) GB1438337A (bs)
IT (1) IT1052119B (bs)
KE (1) KE2823A (bs)
NL (1) NL184782C (bs)
NO (1) NO138565C (bs)
SE (1) SE390819B (bs)
YU (1) YU39914B (bs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1047702B (it) * 1975-07-24 1980-10-20 Acraf Nuova sintesi degli psicofarmaci denominati trazodone ed eteroperidone
US4162318A (en) * 1976-05-05 1979-07-24 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Use of trazodone and etoperidone in Parkinsonism and in other extrapyramidal syndromes characterized by tremors
IT1073639B (it) * 1976-05-05 1985-04-17 Acraf Impiego del trazodone e etoperidone nel morbo di parikinson ed in altre sindromi extrapiramidali caratterizzate da tremori
US4465683A (en) * 1979-09-14 1984-08-14 Mead Johnson & Company Anti-psychotic agents
US4254124A (en) * 1979-09-24 1981-03-03 Mead Johnson & Company Antidepressant agent
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives
US4386091A (en) * 1982-02-24 1983-05-31 Mead Johnson & Company 2-Phenoxyalkyl-1,2,4-triazol-3-one antidepressants
US4575555A (en) * 1983-06-29 1986-03-11 Mead Johnson & Company 4-(3-Chlorophenyl)-1,2,3,6-tetrahydropyridine derivative
US4613600A (en) * 1983-09-30 1986-09-23 Mead Johnson & Company Antidepressant 1,2,4-triazolone compounds
US4784998A (en) * 1987-04-06 1988-11-15 Bristol-Myers Company 1,3,4-oxadiazole pyschotropic compounds
US4931445A (en) * 1988-10-06 1990-06-05 Irwin Goldstein Agents for treatment of male impotence
US5229406A (en) * 1990-09-19 1993-07-20 G. D. Searle & Co. 1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
US5140036A (en) * 1990-09-19 1992-08-18 G. D. Searle & Co. 1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
US5087634A (en) * 1990-10-31 1992-02-11 G. D. Searle & Co. N-substituted imidazol-2-one compounds for treatment of circulatory disorders
US5238952A (en) * 1990-10-31 1993-08-24 G. D. Searle & Co. N-substituted imidazol-2-one compounds for treatment of circulatory disorders
US5196537A (en) * 1991-03-21 1993-03-23 G. D. Searle & Co. 5-apylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
US5164403A (en) * 1991-04-05 1992-11-17 G. D. Searle & Co. N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders
IT1256387B (it) * 1992-11-13 1995-12-04 Acraf Procedimento per preparare triazoloni
CA2182241C (en) * 1996-07-29 2002-09-17 Bo Lei Methods for the manufacture of nefazodone
ES2152860B1 (es) * 1998-10-23 2001-08-16 Finaf 92 Sa Forma cristalina de la nefazodona y procedimiento para su preparacion.
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors

Also Published As

Publication number Publication date
DK141750C (bs) 1980-11-03
ATA871173A (de) 1976-08-15
AT336021B (de) 1977-04-12
DE2351739C3 (de) 1980-09-04
NL184782C (nl) 1989-11-01
FI58495B (fi) 1980-10-31
NL7314204A (bs) 1974-04-18
DE2351739B2 (de) 1980-01-10
SE390819B (sv) 1977-01-24
IT1052119B (it) 1981-06-20
BE806146A (fr) 1974-02-15
NO138565C (no) 1978-09-27
YU263473A (en) 1983-02-28
JPS4993381A (bs) 1974-09-05
US3857845A (en) 1974-12-31
NL184782B (nl) 1989-06-01
DK141750B (da) 1980-06-09
YU39914B (en) 1985-06-30
CA1013746A (en) 1977-07-12
JPS5550948B2 (bs) 1980-12-20
FR2202702A1 (bs) 1974-05-10
NO138565B (no) 1978-06-19
FI58495C (fi) 1981-02-10
ES419687A1 (es) 1976-10-16
GB1438337A (bs) 1976-06-03
KE2823A (en) 1978-03-31
FR2202702B1 (bs) 1976-07-02
DE2351739A1 (de) 1974-04-18
CH589643A5 (bs) 1977-07-15

Similar Documents

Publication Publication Date Title
AR204086A1 (es) Procedimiento para la preparacion de 1-(3-(4-m.clorofenil-1-piperazinil)-propil)-3,4-dietil-delta21,2,4-triazolino-5-ona
AR194298A1 (es) Procedimiento para la preparacion de derivados de 1,2,4-triazoles sustituidos
AR210988A1 (es) Procedimiento para la produccion de derivados de 4,6-didesoxi-4-aminoglucopirano.
AR202224A1 (es) Procedimiento para la obtencion de 1,4-benzodiacepin-2-onas
AR199011A1 (es) Derivados de beta-glutamil-p-nitro-anilida, para la determinacion de la beta-glutamiltranspeptidasa
AR204926A1 (es) Procedimiento para la preparacion de 2,2,6,6-tetrametil-4-oxopiperidina
AR195391A1 (es) Procedimiento para la preparacion de aldehido 3,4,5-triometoxibenzoico
AR203451A1 (es) Procedimiento para la obtencion de nuevas 1,4,5,6,-tetrahidro-piridinas 3-sustituidas
AR192232A1 (es) Procedimiento para la preparacion de nuevos derivados de 1,2,3,4-tetrahidroisoquinolina
AR196775A1 (es) Procedimiento para la preparacion de derivados de 1-(3-(5,6,7,8-tetrahidronaft-1-ii-oxi)-propil)- piperazina
AR207951A1 (es) Procedimiento para la produccion de nuevos derivados de n-(3-alquilcarbonilamino-2,4,6-triyodobenzoil)-aminoacidos
AR200007A1 (es) Procedimiento para la preparacion de nuevos oxazoles 2,4,5-trisustituidos
AR208393A1 (es) Procedimiento para la preparacion de 2,2,6,6-tetrametil-4-oxopiperidina
AR206508A1 (es) Procedimiento para preparar derivados de 1-aminometil-2,2-diaril-ciclopropanocarboxamida
AR201114A1 (es) Procedimiento para la elaboracion de nuevas aza -10,11-dihidro 5-h-dibenzo<b,e>-<1,4>-diazepinas
AR202805A1 (es) Metodo para la preparacion de tiaxantenos, fluor-substituidos
AR196846A1 (es) Procedimiento para la produccion de compuestos de quinazonalina 2-4diamino-6-sustituidos (0 5,6-disustituidos
AR200162A1 (es) Procedimiento para la preparacion de derivados 1,2,4-triazolicos
AR202999A1 (es) Procedimiento para la preparacion de 1,4-ioxido de 2-(2oxazolin-2-il)-3-metilquinoxalina
AR210987A1 (es) Procedimiento para la preparacion de 1-alquilo inferior-2-ciano-7-halogeno- 1,4-benzodiacepinas.
MX9203790A (es) Un procedimiento para la preparacion de nuevos 11,11-alcohiliden-esteroides.
AR205722A1 (es) Procedimiento para la preparacion de derivados de 17a - substituidos - d - homo - 4 - pregnen - 3,20 - diona
AR202001A1 (es) Procedimiento para la preparacion de derivados de 3,5-diyodosalicilanilidas
AR199003A1 (es) Procedimiento para la preparacion de fluorhidrato, clorhidrato o bromhidrato de 2,2'-anhidro-1-beta - d - arabino - furanosil-5-fluorocitosina
AR194812A1 (es) Procedimiento para la preparacion de diisoquinolildipiridil-butanos,y sales de ellos